Project Grant R21HD123150
Award Date 9/1/26
Completion Date 8/31/28
Dollars Obligated $427K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Atlanta, GA 30322, USA
Similar Awards
- The National Institute of Child Health and Human Development awarded Emory University $639,857 on June 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865, Assistance Listing 93.HDR) to conduct longitudinal magnetic resonance imaging assessment of the maternal obesity-placenta-brain axis from gestation through infancy. The study addresses pre-pregnancy obesity affecting 29 percent of U.S. pregnant women and its impact on perinatal neurodevelopment and...
- The National Institute of Child Health and Human Development awarded Brigham & Women's Hospital Inc. $597,571 on September 3, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to validate and implement an artificial intelligence-enhanced tool for real-time prediction of postpartum hemorrhage risk integrated into the electronic health record. The project spans five years through August 31, 2031, with performance at the hospital in Boston,...
- The National Institute of Child Health and Human Development awarded Amahealth LLC $626,360 on September 17, 2025, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to develop an artificial intelligence method that predicts the timing of labor onset using physiological data from non-invasive wearable sensors. Over an eight-month period of performance ending October 31, 2026, Amahealth will enhance its existing work to interpret maternal vital sign patterns...
- This Project Grant award from the Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development provides $769,916 to Emergent Biotechnologies LLC for research into a novel therapy for preeclampsia. The funding supports Phase 1 of developing and characterizing a handle region peptide as an innovative treatment for preeclampsia under the Child Health and Human Development Extramural Research program (CFDA 93.865). Phase 1 work will...
- The National Institute of Child Health and Human Development awarded The General Hospital Corporation (Massachusetts General Hospital) $443,954 on June 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to conduct a four-year mixed-methods assessment of obstetric readiness in low-resource emergency departments. The research addresses the clinical gap created by closures of labor and delivery units that leave 2.3 million women of childbearing age in...
- The National Institute of Child Health and Human Development awarded the Regents of the University of Michigan $598,644 on July 8, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to develop a non-invasive ultrasound technique for detecting preeclampsia and fetal growth restriction through simultaneous assessment of maternal and fetal blood flow components in the placenta. The research uses spectral analysis of umbilical venous pulse wave patterns to...
- The National Institute of Child Health and Human Development awarded Emory University $415,711 on August 26, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to develop a Bayesian hierarchical estimation framework for reconstructing under-five population counts at the small-area level, correcting for persistent undercount bias and multi-source uncertainty in Census data. The research addresses systematic undercounting of children under age five in...
- The National Institute of Child Health and Human Development awarded $453,698 to Brigham & Women's Hospital Inc. on August 20, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to develop and validate chemogenetic animal models of preeclampsia for identifying novel pharmacological targets. The research exploits a transgenic mouse line expressing a recombinant yeast D-amino acid oxidase that generates hydrogen peroxide in vascular endothelium when...
- The National Institute of Child Health and Human Development, part of the Department of Health and Human Services National Institutes of Health, awarded $456,500 to The University of Texas Southwestern Medical Center on June 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865). The award funds molecular characterization of human pregnancy-induced cervical epithelium through two research aims. First, the recipient will apply single-cell and spatial...
- The National Institute of Child Health and Human Development awarded Thomas Jefferson University $438,910 on August 17, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to develop and pilot a group-based well-child care model that integrates maternal healthcare for mothers with hypertensive disorders of pregnancy. The recipient will execute two primary aims. In Aim 1, the institution will conduct a user-centered design process including focus groups...